Literature DB >> 20191345

Tribuli fructus constituents protect against tacrine-induced cytotoxicity in HepG2 cells.

Erisa Byun1, Gil-Saeng Jeong, Ren-Bo An, Tae Sun Min, Youn-Chul Kim.   

Abstract

A new phenolic amide, tribulusimide D (4-hydroxy-N-[3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl]-3-methoxybenzamide) (1), together with a known phenolic amide, terrestriamide ((E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)-2-oxoethyl]-prop-2-enamide) (2) and a flavonol glycoside, quercetin-3-O-beta-D-glucopyranosyl-(1-->6)-beta-D-glucopyranoside (3) were isolated from the H2O extract of Tribuli Fructus. Compounds 1 and 3 showed significant hepatoprotective activities, with EC50 values of 13.46 +/- 0.2 and 7.06 +/- 0.7 microM, respectively, against tacrine-induced cytotoxicity in HepG2 cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20191345     DOI: 10.1007/s12272-010-2226-6

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  3 in total

1.  The cytoprotective effect of sulfuretin against tert-butyl hydroperoxide-induced hepatotoxicity through Nrf2/ARE and JNK/ERK MAPK-mediated heme oxygenase-1 expression.

Authors:  Dong-Sung Lee; Kyoung-Su Kim; Wonmin Ko; Bin Li; Gil-Saeng Jeong; Jun-Hyeog Jang; Hyuncheol Oh; Youn-Chul Kim
Journal:  Int J Mol Sci       Date:  2014-05-19       Impact factor: 5.923

2.  Quercetin-3-O-β-d-glucopyranosyl-(1 → 6)-β-d-glucopyranoside suppresses melanin synthesis by augmenting p38 MAPK and CREB signaling pathways and subsequent cAMP down-regulation in murine melanoma cells.

Authors:  Hyun Gug Jung; Han Hyuk Kim; Souren Paul; Jae Yoon Jang; Yong Hun Cho; Hyeon Jeong Kim; Jae Myo Yu; Eun Su Lee; Bong Jeun An; Sun Chul Kang; Byung Ho Bang
Journal:  Saudi J Biol Sci       Date:  2015-03-26       Impact factor: 4.219

3.  Effects of the Fruit Extract of Tribulus terrestris on Skin Inflammation in Mice with Oxazolone-Induced Atopic Dermatitis through Regulation of Calcium Channels, Orai-1 and TRPV3, and Mast Cell Activation.

Authors:  Seok Yong Kang; Hyo Won Jung; Joo Hyun Nam; Woo Kyung Kim; Jong-Seong Kang; Young-Ho Kim; Cheong-Weon Cho; Chong Woon Cho; Yong-Ki Park; Hyo Sang Bae
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-14       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.